
Novoheart
Hong Kong, Hong Kong SAR China novoheart.com From their website, Nov 2026
Work here? Claim this listing
About
Novoheart develops bioengineered human heart constructs for drug discovery, disease modeling, and screening. It serves researchers and drug developers working on cardiac therapeutics, with laboratory locations in Boston, Hong Kong, and a Singapore facility coming soon.
Services
Human embryonic or induced pluripotent stem cell differentiation to ventricular cardiomyoc
Differentiates pluripotent stem cells into ventricular cardiomyocytes.
Mini-Heart engineered tissue assays using specified cell lines
Provides engineered human heart tissue assays built from specified cell lines.
Human Ventricular Cardiac Anisotropic Sheet (hvCAS)
Offers anisotropic sheet assays for cardiac modeling and testing.
Human Ventricular Cardiac Tissue Strip (hvCTS)
Offers tissue strip assays for contractility and related cardiac functional testing.
Human Heart-in-a-Jar™ / Human Ventricular Cardiac Organoid Chamber (hvCOC)
Provides a human heart-in-a-jar organoid chamber model for testing toxicity and efficacy.
Drug discovery
Supports drug discovery using human-specific cardiac models.
Cardiotoxicity screening
Screens compounds for cardiac toxicity.
Disease modeling of rare/genetic and acquired heart diseases
Builds disease models for rare, genetic, and acquired heart diseases.
5 more services
- Efficacy studies
- Dose titration and optimization
- Patient cohort-specific responses to drug treatments
- Screening and phenotyping services
- Research and development / consultation related to new disease models and therapeutics
Capabilities
- Assays and studies
- Patch clamp
- Electrophysiology
- Arrhythmia
- Contractility
- Pressure-volume
- Toxicity
5 more
- Efficacy
- Screening
- Phenotyping
- Dose response
- Cardiotoxicity
- Therapeutic areas
- Heart disease
- Cardiac therapeutics
- Drug discovery
Instruments and platforms
- CTScreen System Software
- Mini-Heart T-Monitor
- Mini-Heart T-Processor
- Mini-Heart T-Analyzer
Modalities and species
- Modalities
- Gene and cell products
- Species and models
- Human pluripotent stem cells
- Human embryonic stem cells
- Human induced pluripotent stem cells
- Human ventricular cardiomyocytes
- Heart failure with preserved ejection fraction
- COVID
3 more
- Arrhythmias
- Long QT Syndrome
- Friedreich's Ataxia
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Details
- Founded
- 2014
- Office
- 6 Tide Street, 2nd Floor, Boston, MA 02210, USA
- Sites
- Boston, USA
- Serves
- Global
Public records
- Parent company
- Novoheart Holdings Inc. · CA GLEIF